SLE Market Size Worth $3.08 Billion By 2025 | Key Industry Players Roche, Pfizer, Novartis, Bayer9/24/2018 San Francisco, 24 September 2018 - The global systemic lupus erythematosus market size is expected to reach USD 3.08 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.0% during the forecast period.Introduction of new biological therapies, which will add to treatment alternatives and medication costs, in the development pipeline is estimated to fuel revenue generation of the market. Certain new promising drugs that are currently in Phase III trials are anticipated to augment the market as these drugs may target the lupus nephritis patient subset with few effective alternatives and significant unmet needs to be met. This factor is likely to have a strong impact on the market as nearly 50.0% of SLE patients suffer with lupus nephritis.
Use of approved biologic, Benlysta, through clinical studies, has revealed drastic improvements and substantial decrease in consumption of anti-inflammatory glucocorticoids in moderate SLE cases. GSK’s current initiatives center on further increasing opportunities for Benlysta. The company is conducting indication expansion clinical trials, combination therapy studies with rituximab, and new product development, to widen opportunities for its therapy. In this direction, recent launch of Benlysta’s subcutaneous formulation in several countries is expected to boost the SLE market over the forecast period. Full Research Report On Global Systemic Lupus Erythematosus Market By Grand View Research: www.grandviewresearch.com/industry-analysis/systemic-lupus-erythematosus-sle-market Further key findings from the report suggest:
www.grandviewresearch.com/industry/pharmaceuticals Grand View Research has segmented the global systemic lupus erythematosus market by drug class, route of administration, and region: Systemic Lupus Erythematosus Drug Classes Outlook (Revenue, USD Million, 2014 - 2025)
www.grandviewresearch.com/press-release/global-systemic-lupus-erythematosus-sle-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. For More Information: www.grandviewresearch.com
0 Comments
Leave a Reply. |